The US FDA (Food and Drug Administration) has changed the scope of emergency use permission for the new coronavirus vaccine of the major pharmaceutical company Pfizer, and expanded the age of vaccination to children aged 5 to 11 years.
In response to this, the CDC = Centers for Disease Control and Prevention is expected to decide whether to recommend vaccination early next month, and if it is recommended, vaccination will start promptly.
The FDA announced on the 29th that it will change the emergency use authorization for Pfizer's new coronavirus vaccine so that children aged 5 to 11 can also be vaccinated.
As with children over 12 years old, children of the target age need to be vaccinated twice every 3 weeks, but the component of the vaccine to be inoculated at one time is 10 micrograms, which is one third of 12 years old and over. It has been with.
With the FDA's permission, the CDC is expected to meet on the 2nd of next month with a committee of experts to decide whether to recommend vaccination, and if so, vaccination is expected to begin promptly.
According to the CDC, approximately 8,300 children aged 5 to 11 have been hospitalized with the new coronavirus and 146 have died so far in the United States.
According to a survey by the American Academy of Pediatrics, more than 117,000 children, or a quarter of those infected during the week from 14th to 21st of this month, were children.
It will be interesting to see if the expansion of vaccination coverage will stop the spread of infections in children, which is becoming more serious.